ArticleProceedings of the National Academy of Sciences of the United States of America2019
ARF6 and AMAP1 are major targets of
Open access · greenAbstract read
In one paragraph
Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.
0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
11.1field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
95 citing papers in PubMed, 159 citations in OpenAlex.
- Programmed cell death protein 4 (PDCD4): a pleiotropic regulator in cardiovascular diseases.Journal of physiology and biochemistry · 2026Review
- Review
- Peptides as integrative modulators for clinical prognosis and targeted therapy in pancreatic cancer.Discover oncology · 2026Review
- RAS signaling and remodeling of the immune microenvironment in pancreatic ductal adenocarcinoma: implications of emerging RAS-targeted therapy.Frontiers in cell and developmental biology · 2026Review
- Intracellular PD-L1: Functions, Regulation, and Therapeutic Implications.International journal of biological sciences · 2026Review
- Responsive nanomedicine strategies achieve pancreatic cancer precise theranostics.Bioactive materials · 2026Review
- Surfactant Protein B Precursor Inhibit the Progression of Resectable Non-small Cell Lung Cancer by Suppressing eIF4F-mediated Immune Evasion and Cancer Stemness.International journal of biological sciences · 2026Article
- CRISPR-Cas9 screening reveals G2E3 as a novel ubiquitin-linked factor controlling autophagosome-lysosome fusion and cancer cell progression.Cell death discovery · 2025Article
- KRAS mutation promotes immune escape of lung adenocarcinoma via ZNF24/SLC7A5/PD-L1 axis.BMC cancer · 2025Article
- Precision immune regulation in KRAS-mutated cancers: the final piece of the puzzle?Journal of experimental & clinical cancer research : CR · 2025Review
- Identification and validation of ARF6 for a potential prognostic biomarker of acute myeloid leukemia.Cancer cell international · 2025Article
- Methuosis key gene ARF6 as a diagnostic, prognostic and immunotherapeutic marker for prostate cancer: based on a comprehensive pan-cancer multi-omics analysis.Discover oncology · 2025Article
- ARF6 Promotes AML Progression via Activation of PI3K/AKT/mTOR Signaling.Cancer medicine · 2025Article
- KRAS Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation and the Potential of Immunotherapy.Cancers · 2025Review
- Polyphenols in Pancreatic Cancer Management: Exploring the Roles and Mechanisms of Resveratrol and Epigallocatechin.Oncology research · 2025Review
- Effect of cytotoxic CD8+ T-cells secretory proteins on hypoxic pancreatic cancer cells.PloS one · 2025Article
- Acute aerobic exercise alters serum protein distribution in colorectal cancer patients.Frontiers in oncology · 2025Article
- ArfGAP with the SH3 Domain, Ankyrin Repeat and PH Domain 1 Inversely Regulates Programmed Death-Ligand 1 Through Negative Feedback of Phosphorylated Epithelial Growth Factor Receptor and Activation of Nuclear Factor-Kappa B in Non-Small Cell Lung Cancer.Cancer management and research · 2025Article
- DRG2 as a Biomarker to Enhance the Predictive Efficacy of PD-L1 Immunohistochemistry Assays.Biomedicines · 2024Article
- Components of the Endosome-Lysosome Vesicular Machinery as Drivers of the Metastatic Cascade in Prostate Cancer.Cancers · 2024Review
35 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 5 institutions in 2 countries.
Shigeru HashimotoDepartment of Molecular Biology, Hokkaido University Graduate School of Medicine, 060-8638 Sapporo, Japan.
Shotaro FurukawaDepartment of Molecular Biology, Hokkaido University Graduate School of Medicine, 060-8638 Sapporo, Japan.
Ari HashimotoDepartment of Molecular Biology, Hokkaido University Graduate School of Medicine, 060-8638 Sapporo, Japan.
Akio TsutahoDepartment of Molecular Biology, Hokkaido University Graduate School of Medicine, 060-8638 Sapporo, Japan.
Akira FukaoLaboratory of Biochemistry, Graduate School of Pharmaceutical Sciences, Kindai University, 577-8502 Osaka, Japan.
Yurika SakamuraLaboratory of Biochemistry, Graduate School of Pharmaceutical Sciences, Kindai University, 577-8502 Osaka, Japan.
Gyanu ParajuliLaboratory of Immune Regulation, World Premier International Research Center Initiative Immunology Frontier Research Center, Osaka University, 565-0871 Osaka, Japan.
Yasuhito OnoderaDepartment of Molecular Biology, Hokkaido University Graduate School of Medicine, 060-8638 Sapporo, Japan.
Yutaro OtsukaDepartment of Molecular Biology, Hokkaido University Graduate School of Medicine, 060-8638 Sapporo, Japan.
Haruka HandaDepartment of Molecular Biology, Hokkaido University Graduate School of Medicine, 060-8638 Sapporo, Japan.ORCID 0000-0002-8557-7479
Tsukasa OikawaDepartment of Molecular Biology, Hokkaido University Graduate School of Medicine, 060-8638 Sapporo, Japan.
Soichiro HataDepartment of Molecular Biology, Hokkaido University Graduate School of Medicine, 060-8638 Sapporo, Japan.
Yoshihiro NishikawaDepartment of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 606-8507 Kyoto, Japan.ORCID 0000-0002-1113-6937
Yusuke MizukamiDivision of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, 078-8510 Asahikawa, Japan.ORCID 0000-0002-1068-7024
Yuzo KodamaDepartment of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 606-8507 Kyoto, Japan.
Masaaki MurakamiDivision of Molecular Psychoimmunology, Institute for Genetic Medicine and Graduate School of Medicine, Hokkaido University, 060-0815 Sapporo, Japan.
Toshinobu FujiwaraLaboratory of Biochemistry, Graduate School of Pharmaceutical Sciences, Kindai University, 577-8502 Osaka, Japan.
Satoshi HiranoDepartment of Gastroenterological Surgery II, Hokkaido University Graduate School of Medicine, 060-8638 Sapporo, Japan.
Hisataka SabeDepartment of Molecular Biology, Hokkaido University Graduate School of Medicine, 060-8638 Sapporo, Japan; sabeh@med.hokudai.ac.jp.
Hokkaido University · JPKindai University · JPKyoto University · JPAsahikawa Medical University · JPOsaka International University · JP
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although
Indexed as
ADP-Ribosylation Factor 6ADP-Ribosylation FactorsB7-H1 AntigenBinding SitesBiomarkers, TumorCell Line, TumorGene Expression Regulation, NeoplasticHumansImmune EvasionImmunohistochemistryModels, MolecularMutationPancreatic NeoplasmsPrognosisProtein BindingProto-Oncogene Proteins p21(ras)ADP-Ribosylation Factor 6ADP-Ribosylation FactorsARF6 protein, humanArf6 protein, mouseB7-H1 AntigenBiomarkers, TumorCD274 protein, humanKRAS protein, humanProto-Oncogene Proteins p21(ras)Receptors, Platelet-Derived Growth FactorRNA, MessengerTP53 protein, humanTumor Suppressor Protein p53ARF6mevalonate pathwaymRNA translationpancreatic driver oncogenesPD-L1
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.